Details for New Drug Application (NDA): 202938
✉ Email this page to a colleague
The generic ingredient in HYDRALAZINE HYDROCHLORIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.
Summary for 202938
Tradename: | HYDRALAZINE HYDROCHLORIDE |
Applicant: | Navinta Llc |
Ingredient: | hydralazine hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202938
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
Approval Date: | Mar 28, 2013 | TE: | AP | RLD: | No |
Complete Access Available with Subscription